BD Onclarity™ HPV Assay

Nazione: Singapore

Lingua: inglese

Fonte: HSA (Health Sciences Authority)

Commercializzato da:

BECTON DICKINSON HOLDINGS PTE. LTD.

Classe:

Class C IVD

Prodotto da:

Becton, Dickinson and Company (BD)

Area terapeutica:

Microbiology

Indicazioni terapeutiche:

The BD Onclarity™ HPV Assay is an amplified DNA test for the qualitative detection of high risk types of human papillomavirus (HPV). The assay detects all high risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) and provides the capability for genotyping of six high risk types (HPV 16, 18, 31, 45, 51 and 52). Cervical specimens that are tested with the BD Onclarity HPV Assay include the BD Onclarity HPV Cervical Brush Collection Kit, BD SurePath™ Preservative Fluid, and PreservCyt® Solution (using an aliquot that is removed prior to or after processing for either the BD SurePath or ThinPrep™ Pap test). The BD Onclarity HPV Assay is performed with the BD Viper™ LT System.

Dettagli prodotto:

Models: BD Onclarity™ HPV Assay - 442946, BD Viper™ PCR Extraction Reagent Trough with Piercing Tool - 442841, BD FOX™ PCR Extraction Tubes - 441992, Control set for the BD Onclarity™ HPV Assay - 441993, BD Onclarity™ HPV Liquid Based Cytology Specimen (LBC) Diluent Tubes - 442840, BD Viper™ LT System Instrument - 442839

Data dell'autorizzazione:

2019-08-05